Bio-Rad Laboratories Shares Outstanding 2010-2022 | BIO.B

Bio-Rad Laboratories shares outstanding history from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Bio-Rad Laboratories shares outstanding for the quarter ending June 30, 2022 were 0.030B, a 1.17% decline year-over-year.
  • Bio-Rad Laboratories 2021 shares outstanding were 0.03B, a 0.16% increase from 2020.
  • Bio-Rad Laboratories 2020 shares outstanding were 0.03B, a 0.08% decline from 2019.
  • Bio-Rad Laboratories 2019 shares outstanding were 0.03B, a 0.15% decline from 2018.
Bio-Rad Laboratories Annual Shares Outstanding
(Millions of Shares)
2021 30
2020 30
2019 30
2018 30
2017 30
2016 30
2015 29
2014 29
2013 29
2012 29
2011 28
2010 28
2009 28
Bio-Rad Laboratories Quarterly Shares Outstanding
(Millions of Shares)
2022-06-30 30
2022-03-31 30
2021-12-31 30
2021-09-30 30
2021-06-30 30
2021-03-31 30
2020-12-31 30
2020-09-30 30
2020-06-30 30
2020-03-31 30
2019-12-31 30
2019-09-30 30
2019-06-30 30
2019-03-31 30
2018-12-31 30
2018-09-30 30
2018-06-30 30
2018-03-31 30
2017-12-31 30
2017-09-30 30
2017-06-30 30
2017-03-31 30
2016-12-31 30
2016-09-30 30
2016-06-30 30
2016-03-31 30
2015-12-31 29
2015-09-30 29
2015-06-30 29
2015-03-31 29
2014-12-31 29
2014-09-30 29
2014-06-30 29
2014-03-31 29
2013-12-31 29
2013-09-30 29
2013-06-30 29
2013-03-31 29
2012-12-31 29
2012-09-30 29
2012-06-30 29
2012-03-31 29
2011-12-31 28
2011-09-30 28
2011-06-30 28
2011-03-31 28
2010-12-31 28
2010-09-30 28
2010-06-30 28
2010-03-31 28
2009-12-31 28
2009-09-30 28
2009-06-30 28
2009-03-31 28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.008B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $157.582B 9.56
GSK (GSK) United Kingdom $81.978B 9.84
QIAGEN (QGEN) Netherlands $11.229B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $10.520B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.756B 0.00
Arcus Biosciences (RCUS) United States $1.974B 38.52
Emergent Biosolutions (EBS) United States $1.523B 8.83
Myovant Sciences (MYOV) United Kingdom $1.503B 0.00
Zymeworks (ZYME) Canada $0.405B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SQZ Biotechnologies (SQZ) United States $0.098B 0.00
Gelesis Holdings (GLS) United States $0.098B 0.00
Ambrx Biopharma (AMAM) United States $0.092B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00